UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000030290
Receipt No. R000034585
Scientific Title Blood endotoxin levels in impaired glucose tolerance and diabetes: prospective study
Date of disclosure of the study information 2017/12/07
Last modified on 2020/12/08 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Blood endotoxin levels in impaired glucose
tolerance and diabetes: prospective study
Acronym Blood endotoxin levels and glucose metabolism
Scientific Title Blood endotoxin levels in impaired glucose
tolerance and diabetes: prospective study
Scientific Title:Acronym Blood endotoxin levels and glucose metabolism
Region
Japan

Condition
Condition impaired glucose tolerance (IGT) and diabetes mellitus (DM)
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Comparison of blood endotoxin levels between at admission and discharge in treatment of diabetes.
Basic objectives2 Others
Basic objectives -Others N/A
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Comparison of blood endotoxin levels between at admission and discharge in treatment of diabetes.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria Impaired glucose tolerance and diabetes mellitus
Key exclusion criteria 1)Acute phase of infection
2)Digestive disease
Target sample size 20

Research contact person
Name of lead principal investigator
1st name Hideki
Middle name
Last name Katagiri
Organization Tohoku University Hospital
Division name Department of Daibetes and Metabolism
Zip code 980-8577
Address Seiryo-machi 1-1, Aoba-ku, Sendai, Miyagi
TEL 022-717-7779
Email ssawada@med.tohoku.ac.jp

Public contact
Name of contact person
1st name Shojiro
Middle name
Last name Sawada
Organization Tohoku University Hospital
Division name Department of Daibetes and Metabolism
Zip code 980-8577
Address Seiryo-machi 1-1, Aoba-ku, Sendai, Miyagi
TEL 022-717-7779
Homepage URL
Email ssawada@med.tohoku.ac.jp

Sponsor
Institute Tohoku University Hospital
Institute
Department

Funding Source
Organization Tohoku University Hospital
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Tohoku University Hospital
Address Seiryo-machi 1-1, Aoba-ku, Sendai, Miyagi
Tel 022-717-7779
Email ssawada@med.tohoku.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 12 Month 07 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2017 Year 12 Month 06 Day
Date of IRB
2018 Year 05 Month 16 Day
Anticipated trial start date
2018 Year 01 Month 15 Day
Last follow-up date
2020 Year 12 Month 07 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information N/A

Management information
Registered date
2017 Year 12 Month 06 Day
Last modified on
2020 Year 12 Month 08 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000034585